Tatsuno Keita, Ikeda Mahoko, Wakabayashi Yoshitaka, Yanagimoto Shintaro, Okugawa Shu, Moriya Kyoji
Department of Infection Control and Prevention, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
Infect Dis Ther. 2019 Sep;8(3):343-352. doi: 10.1007/s40121-019-00257-6. Epub 2019 Jul 31.
This study aimed to compare the clinical characteristics and prognoses of central venous catheter-associated bloodstream infections (CVC-BSIs) with peripheral venous catheter-associated BSIs (PVC-BSIs).
This retrospective observational study was conducted between April 2011 and March 2013 at a teaching hospital in Tokyo, Japan. Adult patients who developed CVC-BSIs and PVC-BSIs more than 2 days after admission were included. Patients with both CVC-BSIs and PVC-BSIs were excluded. Clinical characteristics of patients with CVC-BSIs and PVC-BSIs were obtained from medical records, and 30-day all-cause mortality was measured as the clinical outcome.
We enrolled 124 PVC-BSI cases and 110 CVC-BSI cases. Median age, age-adjusted Charlson score, Sequential Organ Failure Assessment score, sex, and ward type at BSI onset did not differ significantly between the two groups. The median duration of catheter indwelling was significantly shorter in the PVC-BSI group than in the CVC-BSI group. Staphylococcus aureus and Gram-negative bacilli infections were more frequent and coagulase-negative staphylococci (CNS) and Candida spp. infections were less frequent in the PVC-BSI group than in the CVC-BSI group. The prevalence of oxacillin resistance among causative S. aureus and CNS, 30-day all-cause mortality, and appropriateness of empirical and definitive antimicrobial therapies did not differ significantly between the two groups.
The pathogen species distribution varies between PVC-BSIs and CVC-BSIs. However, all-cause mortality does not differ between the two groups. PVCs are not safer than CVCs with respect to BSIs; therefore, it is necessary to use similar precautions relevant to CVC use in order to avoid unnecessary use of PVCs.
本研究旨在比较中心静脉导管相关血流感染(CVC-BSIs)与外周静脉导管相关血流感染(PVC-BSIs)的临床特征和预后。
本回顾性观察性研究于2011年4月至2013年3月在日本东京的一家教学医院进行。纳入入院2天以上发生CVC-BSIs和PVC-BSIs的成年患者。同时发生CVC-BSIs和PVC-BSIs的患者被排除。从病历中获取CVC-BSIs和PVC-BSIs患者的临床特征,并将30天全因死亡率作为临床结局进行测量。
我们纳入了124例PVC-BSI病例和110例CVC-BSI病例。两组患者的中位年龄、年龄校正Charlson评分、序贯器官衰竭评估评分、性别以及BSI发生时的病房类型无显著差异。PVC-BSI组的导管留置中位时间显著短于CVC-BSI组。PVC-BSI组中金黄色葡萄球菌和革兰氏阴性杆菌感染更为常见,凝固酶阴性葡萄球菌(CNS)和念珠菌属感染比CVC-BSI组少见。两组之间致病性金黄色葡萄球菌和CNS对苯唑西林的耐药率、30天全因死亡率以及经验性和确定性抗菌治疗的恰当性无显著差异。
PVC-BSIs和CVC-BSIs的病原体种类分布有所不同。然而,两组的全因死亡率并无差异。就BSIs而言,PVC并不比CVC更安全;因此,有必要采取与使用CVC类似的预防措施,以避免不必要地使用PVC。